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ABSTRACT 
Background: 25(OH) D is an important component for human health. Vitamin D deficiency is a worldwide problem. Previous 
epidemiological studies have shown the association of this deficiency with development of other chronic disease that also 
increase the morbidity. So early detection of deficiency helps to plan intervention and treatment to avoid morbidity. Objective: 
To evaluate the association of vitamin D deficiency in individuals suffering with chronic diseases and the effect of replacement 
therapy on the clinical symptoms of vitamin D deficiency. Method: This study analyzed a total of 115 patients visiting the 
Diabetes and Endocrine Research Centre. Factors such as age, gender, duration of sun exposure and body parts exposed to 
sunshine were studied. The data was recorded on a questionnaire performa.  Patients with 25(OH) D levels below 30ng/ml 
were considered to have insufficient levels. 48 patients who agreed for treatment were given standard loading and maintenance 
dose of vitamin D. 31 Patients reported back after 3 months of maintenance dose treatment. Results: The mean age of patients 
was 47.82±13.86 years.  Duration of sunshine exposure was significantly low with p-value of 0.005. In our study, 
112/115(97.3%) patients were found to have 25(OH) D level below 30ng/ml and 41/115 (21.5%) were severely deficient.  
48(41%) patients agreed for replacement therapy. However, only 31 reported back with vitamin D level. In comparison to 
pretreatment records, there was significant improvement in vitamin D levels after 3 months of treatment.  There was 
improvement with symptoms such as lethargy which improved in 11/17, whereas depression and body aches improved in 
12/19 and 16/26 patients respectively. Conclusion: It is important to recognize the deficiency of vitamin D level in patient 
suffering from chronic diseases in order to avoid other co morbidities. So, this study can help to make policy in future about 
which population needs to be screened and what preventive precautions can be taken. 
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itamin D is a fat soluble vitamin involved in bone 
mineralization. It can be ingested in diet as 
cholecalciferol (Vitamin D3) or ergocalciferol 
(Vitamin D2), but can also be synthesized in skin 
by exposure to sunlight [1]. Vitamin D deficiency can 
manifest at all ages. Common manifestations of Vitamin D 
deficiency are symmetric lower back pain, proximal 
muscle weakness, muscle aches and throbbing bone pain 
elicited with pressure over sternum or tibia [2]. However, 
epidemiological studies have shown low vitamin D level 
associated with high risk of osteoporotic fractures and 
malignancy of breast, colon, ovary and prostate [3]. 
Common causes of vitamin D deficiency include diet low 
in vitamin D and reduced exposure to sunlight [4]. In 
adults, vitamin deficiency is defined as a serum 25-
hydoxyvitamin-D level of less than 20ng/ml [50 nmol/L] 
and insufficiency is defined as serum 25-hydoxyvitamin D 
level of 20-30ng/ml (50-75nmol/L) [5].  
Studies have reported that 25(OH) D deficiency status is 
an unrecognized entity is endemic in both children and 
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adults in the United States [6]. Despite the important role 
of sunlight in vitamin D synthesis, recent studies have 
shown that rate of vitamin D deficiency is still higher in 
the sunniest areas of the world including Middle East 
countries because of low exposure to sunlight due to 
cultural factors [7]. However, there is still debate how 
much vitamin D replacement is needed to correct severe 
vitamin D deficiency. Commonly applied strategy is to 
prescribe a loading dose of 50,000 IU of vitamin D orally 
once a week for 2-3 months or 3 times a week for 1 month 
[8]. Daily requirements of vitamin D is around 800-1000 
IU, but larger doses required for deficient individuals [9]. 
Oral supplementation with 3000–5000 IU daily for 6–12 
weeks can be used to replete stores followed by a 
maintenance dose of 1000–2000 IU per day. Vitamin D 
status should be assessed 3–4 months after commencing 
treatment as vitamin D is stored in fat and muscle and 
there is a lag time before normalization of serum 
concentrations [10]. The present study was conducted to 
see how patients suffering from chronic disease are also 
being affected by hypovitaminosis D and how they 
respond to vitamin D therapy. 
MATERIAL AND METHODS 
The present study was conducted at the Diabetes and 
Endocrine Research Centre of Royal Care Hospital, Sri 
Lanka. Data was collected retrospectively from a total in 
115 symptomatic patients who visited the department from 
June 2017 to march 2018. All patients above 18 years of 
age, diagnosed Diabetic and hypertensive patients with 
clinical signs and symptoms of depression and mood 
disorders were included in study. Patients not willing to be 
a part of the study and those patients on corticosteroids, 
antiepileptic medications and those who were already on 
vitamin D supplements were excluded from the study. 
Informed consent was obtained prior to all the 
investigations and interventions. Variables such as age, 
gender, duration of sun exposure and body parts exposed 
to sunshine were studied. Patients with 25(OH) D levels 
below 30ng/ml are considered insufficient. The data was 
recorded on a questionnaire performa. After initial 
assessment, only 48 patients agreed for vitamin D 
replacement therapy, who were prescribed with Vitamin D 
replacement therapy for 3 months. Patients were started 
with loading dose of 200,000 IU for seven weeks or 
400,000 IU for 2 weeks. Maintenance dose of 1000 to 
2000 /day was given for 3months or 5000/week for 3 
months. Post treatment vitamin D levels were also 
assessed in the same laboratory. All the collected data 
were tabulated and data was analyzed by using IBM SPSS 
version 19. 
RESULTS:  
The present study was conducted to evaluate the effect of 
replacement therapy on clinical symptoms of patients with 
vitamin D deficiency. A total of 115 patients visiting clinic 
of diabetes and endocrine research Centre ranging from 
age 18 years to maximum age up to 76 years were included 
in the study. The mean age of patients was 47.82 with a 
standard deviation of 13.86. Among 115 patients, 69 
(46%) were females and 46 (24%) were males.  Among the 
115 patients, a total of 112(97.3%) were found to have 
vitamin D levels below the normal limits of 30ng/ml. 
Vitamin D levels between 20-30nd/ml were considered 
insufficient, Levels between 10-20 ng/ml was considered 
deficient<10ng/ml were considered severely deficient. In 
our study, 55 (47.8%) patients had deficient levels, 41 
(21.5%) patients were severely deficient and only 16 
(13.7%) patients had insufficient levels of vitamin D. 
Relationship of variables such as gender, age, patient’s 
body exposure areas and duration of sunshine exposure 
with Vitamin D deficiency were assessed. We found p 
value was not significant in this range of age group. So, it 
has been seen that vitamin D deficiency is not related to 
age ranging from 18 to 76 years of age. In our study 
population vitamin D level were found significantly 
deficient with P-value of 0.00. Among the 115 patients, 
face and hand up to wrist were exposed to sunlight in 56 
(29%) patients, head and arms were exposed in 43 (22.3%) 
patients, face and arms, head and hand up to wrist were 
exposed in 7(3.6%) each patients and only 3(1.6%) 
patients were found fully covered. Exposure to sunlight 
was found to be significantly associated with vitamin 
deficiency (P= 0.02). with respect to duration of sunshine 
exposure, 82(42.9%) patients were exposed to less than 10 
minutes of sunshine followed by 22(11.5%) people were 
found to exposed by sunshine for 15-30 minutes. 8 (4.1%) 
patients were exposed to 30-60 minutes of sunlight, 2(1%) 
patients were exposed to 60-90 minutes and prolonged 
exposure to sunshine was noted in only 1(0.5%) patient. 
There was significant association of duration of exposure 
to sunlight with vitamin D deficiency.  
In our study, only 48 patients out of 115 agreed for 
vitamin D replacement therapy.  Clinical symptoms of 
vitamin D deficiency were evaluated in those who agreed 
for treatment. Depression was noted in 29 patients, 
followed by body aches in 26 patients, joint pain, anger in 
24 patients each and lethargy was noted in 17 patients. The 
treatment was solely based on patient’s preference, 
convenience and consent. Suggested route of 
administration of drug was either oral or intramuscular 
route. Oral route was selected by 38(79.2%) patients and 
10(20.8%) patients preferred intramuscular injection. A 
loading dose of 200,000IU weekly for 4 weeks was 
administered in 29(60.4%) patients and 17(35.4%) took 
400,000IU for 2 weeks. This was followed by a 
maintenance dose of 1000IU /day for 11(22.9%) patients, 
2000 IU/day in 32(22.6%) and 5000 IU/week for 5(10.2%) 
patients for a period of 3 months. All patients were advised 
for a follow up visit after 3 months and Vitamin D level 
assessment was carried out. In the follow up visit, only 31 
patients reported back and 17 (35.4%) patients were lost to 
Naser et al                                                                                  Effect of vitamin D replacement therapy 
  
Vol 4| Issue 4| Oct-Dec 2019                                                                                                    Eastern J Med Sci 157 
follow up. There was significant improvement in vitamin 
D levels when compared to pretreatment records. Table 1 
depicts the pre and post treatment vitamin D levels in 
patients. In comparison with post treatment symptomatic 
improvements were seen.  However these results were not 
statistically significant (Table 2, Figure 1). 
Table 1: Compassion of pre and post treatment vitamin 
D levels 
Vitamin D level Pre treatment 
N=31 
Post treatment  
N=31 
>30ng/ml 2(6.4%) 3(6.3%) 
20-29ng/ml 3(9.6%) 19(39.6%) 
10-19ng/ml 16(51.6%) 8(16.7%) 
<10ng/ml 10(32.2%) 1(2.1) 
P value  0.00 
 
DISCUSSION 
The present study was conducted to find the relationship 
between chronic diseases and vitamin D deficiency and the 
effect of replacement therapy in such patients. Patients 
who were suffering from Diabetic and hypertensive 
patients with clinical signs and symptoms of depression 
and mood disorders were included in study and these 
patients were found to have pronounced vitamin D 
deficiency (97.3%). The results of our study are in 
correlation with other studies conducted in different 
regions, patients with poor glycemic control were found to 
have 84% deficient levels as compared to good diabetes 
control patients [11].  Similarly another study detected 
high prevalence of vitamin D deficiency in patients with 
viral hepatitis [12].   
In our study we found that significant association 
between sunlight exposure and vitamin D deficiency. This 
was in accordance with a study by Binkely N et al, who 
also noted significantly low levels of 25(OH) D in patients 
who were exposed to adequate sunlight [13].  Elspeth E 
and colleagues [14]
 
in their study found that decreased sun 
exposure limits the synthesis of vitamin D, moreover they 
found that sun exposure time is increased four to five times 
in naturally dark skinned people than white skin tone 
individuals. Similarly, we also noted that sun exposure 
time in our study population was less than 10 minutes in 
42.9% population, although they require prolong sun 
exposure because of their dark skin tone. The main reason 
for low 25(OH) D production was time of exposure and it 
was significantly low in our study. Moreover our study 
population were dark skinned people. As it’s also proven 
in previous studies dark skinned people suffered from 
more vitamin D deficiency because of poor absorption of 
UV. 
Figure 1: Comparison of symptoms in patients before 
and after treatment 
Yilmaz et al [15] in their study detected significant 
improvement in nonspecific musculoskeletal pain, level of 
depression, lethargy and quality of life with vitamin D 
replacement therapy. Our study also showed improvement 
of clinical symptomatology including lethargy, depression, 
anger, body aches and nonspecific joint pains. Upon 
administration of Vitamin D replacement therapy and 
follow up after 3 months, significant number of patients 
improved from severe deficiency levels to insufficiency 
levels, but still they were not restored to sufficient levels. 
  
Table 2: Clinical symptoms seen in affected population willing for treatment before and after treatment: 
Symptoms Pre treatment P-value 
(Pre treatment 
Improved (Post 
treatment ) 
Not Improved 
(post treatment) 
P-value 
(Post treatment) 
Body aches 26 0.04 16 10 0.42 
Joint pain  24 0.41 14 10 0.17 
Anger 24 0.02 8 16 0.43 
Depression 29 0.55 12 16 0.42 
Lethargy 17 0.87 11 6 0.39 
Although there is no clear guideline to check the serum 
level after repletion, but the goal is to achieve a minimum 
level of 30ng/ml. in case if the values don’t reach  
 
sufficient levels, a second eight week course of 
ergocalciferol should be prescribed.  The probable cause 
for not reaching the normal levels could either be non-
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adherence to therapy or malabsorption. In case of 
malabsorption, consultation with gastroenterologist should 
be considered. After replenishing serum 25-hydroxy 
vitamin D levels, maintenance dosage of Cholecalciferol 
should be instituted at 800-1,000 IU per day along with 
supplemental sources [2]. 
With the above mentioned doses vitamin D 
replacement therapy is normally a safe treatment. It has 
been found vitamin D intoxication has been associated 
only with intakes of 50,000 to 1 million IU/d over the 
course of months or years [5].  So, it’s yet to decide in our 
population about duration of therapy to prevent 
intoxication. Our study was conducted in a single center 
with a small sample size which is a limitation of the study. 
We further recommend this study in a larger population in 
a multicenter unit. Along with the variables used in our 
study other factors such as life style patterns, nutritional 
habits and sunshine exposure especially in places with cold 
climate can also be evaluated. 
CONCLUSION  
Vitamin D deficiency is associated with chronic diseases. 
Currently, Vitamin D levels are below the recommended 
levels in worldwide population. Therefore as one of the 
preventive measures, mass awareness campaign should be 
started on media. In addition to the therapeutic measures, 
food fortification with vitamin D supplementation should 
done. Regular follow up visits during the maintenance 
phase and evaluation of the serum Vitamin D levels are 
also equally important while treating such patients. 
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